IGDI will leverage Ginkgo's Adaptive
Laboratory Evolution technology to improve its sourdough starter
culture product
PADUA, Italy and BOSTON, April 16,
2024 /PRNewswire/ -- Il Granaio delle Idee (IGDI), an
innovative international developer and provider of clean label
baking ingredients, and Ginkgo Bioworks (NYSE: DNA), which is
building the leading platform for cell programming and biosecurity,
today announced a new collaboration. IGDI has identified a new
sourdough bakery strain that can improve the flavor and aroma
profile of baked goods via its starter culture product,
Pater®. This collaboration will leverage Ginkgo's
Adaptive Laboratory Evolution (ALE) technology to accelerate the
growth rate of IGDI's selected strain.
Lactic acid bacteria helps give sourdough its distinctive taste.
IGDI has used its proprietary technology to develop a product,
Pater, that keeps lactic acid bacteria dispersed in flour, viable
and stable over time. Pater is a shelf stable, dried baking mix
that can be used to make sourdough en masse, enabling
artisanal and industrial bakers to expand their potential offerings
of sourdough-based products. Bakers can use Pater to enhance the
flavor, fragrance, structure, and color of bread, improve
digestibility, and extend bread freshness. Additionally, Pater can
produce natural emulsifiers, and can thus lessen the reliance on
chemical additives used widely in the baking industry.
IGDI would like to incorporate a new strain in Pater to further
improve the flavor and aroma of baked goods. In order to grow this
strain economically, IGDI will leverage Ginkgo's ALE technology as
it seeks to evolve the strain towards a higher growth rate. Ginkgo
uses ALE as a fast, powerful strain development tool that can adapt
strains to industrially-relevant conditions without gene
editing.
Federico Allamprese Manes
Rossi, founder and CEO of Il Granaio delle Idee:
"Our
collaboration with Ginkgo Bioworks represents a significant
milestone in our entrepreneurial journey. We've watched Ginkgo
excel in the food and nutrition space for years, and we couldn't be
more excited to work with them. Ginkgo's impressive ALE technology
shows promising potential to rapidly improve the growth rate of our
strain, and distinguish Pater within the market. Together,
we're enhancing product quality, empowering bakers with innovative
solutions that elevate their craft, and preserving the expression
of culture and identity in food."
Simon Trancart, Head of ALE at Ginkgo
Bioworks:
"This collaboration underscores Ginkgo's
commitment to innovation within the food and nutrition industry.
We're thrilled to support Il Granaio delle Idee's vision by
leveraging our strain optimization tools and powerful ALE
technology to elevate their sourdough product to advanced levels of
quality and efficiency. We welcome opportunities like this to help
customers improve their products with Ginkgo's diverse strain
optimization capabilities."
To learn more about Ginkgo's ALE technology, read an interview
with Ginkgo's Head of ALE, Simon Trancart (here), and watch
Ginkgo's Foundry Theory video, Fitter Microbes Faster with
Automated ALE (here).
About Ginkgo Bioworks
Ginkgo Bioworks is the leading horizontal platform for
cell programming, providing flexible, end-to-end services that
solve challenges for organizations across diverse markets, from
food and agriculture to pharmaceuticals to industrial and specialty
chemicals. Ginkgo Biosecurity is building and deploying the
next-generation infrastructure and technologies that global leaders
need to predict, detect, and respond to a wide variety of
biological threats. For more information,
visit ginkgobioworks.com and ginkgobiosecurity.com,
read our blog, or follow us on social
media channels such as X (@Ginkgo and
@Ginkgo_Biosec), Instagram
(@GinkgoBioworks), Threads
(@GinkgoBioworks),
or LinkedIn.
About Il Granaio delle Idee
Il Granaio delle Idee, a company founded in 1998, stands out in
the baking sector for its commitment to producing clean label
products, made with natural raw materials and without the use of
chemical additives. The company offers a wide range of products for
bread making, pastry making and pizza making, including live lactic
acid bacteria, complete mixes, improvers and yeasts, all formulated
to guarantee superior quality products. Among its top product lines
is Pater®, a unique blend based on live lactic acid bacteria and
yeasts that gives baked goods an unparalleled taste and aroma.
Pater® Pasticceria, designed for large leavened products and
croissants, is also formulated with lactic acid bacteria and
enzymes that guarantee an unmistakable melt-in-the-mouth texture.
Il Granaio delle Idee is constantly committed to research and
development of new solutions for the baking sector. Thanks to the
use of cutting-edge enzymatic and live lactic fermentation
technologies, the company is able to offer innovative products that
improve the performance and final yield of baked goods. Il Granaio
delle Idee, with its clean label philosophy and commitment to
innovation, acts as a point of reference for all those seeking high
quality products and services in the baking sector. For more
information, visit www.ilgranaiodelleidee.com
Forward-Looking Statements of Ginkgo Bioworks
This press release contains certain forward-looking statements
within the meaning of the federal securities laws, including
statements regarding the capabilities and potential success of the
partnership and Ginkgo's cell programming platform. These
forward-looking statements generally are identified by the words
"believe," "can," "project," "potential," "expect," "anticipate,"
"estimate," "intend," "strategy," "future," "opportunity," "plan,"
"may," "should," "will," "would," "will be," "will continue," "will
likely result," and similar expressions. Forward-looking statements
are predictions, projections and other statements about future
events that are based on current expectations and assumptions and,
as a result, are subject to risks and uncertainties. Many factors
could cause actual future events to differ materially from the
forward-looking statements in this press release, including but not
limited to: (i) volatility in the price of Ginkgo's securities due
to a variety of factors, including changes in the competitive and
highly regulated industries in which Ginkgo operates and plans to
operate, variations in performance across competitors, and changes
in laws and regulations affecting Ginkgo's business, (ii) the
ability to implement business plans, forecasts, and other
expectations, and to identify and realize additional business
opportunities, (iii) the risk of downturns in demand for products
using synthetic biology, (iv) the uncertainty regarding the demand
for passive monitoring programs and biosecurity services, (v)
changes to the biosecurity industry, including due to advancements
in technology, emerging competition and evolution in industry
demands, standards and regulations, (vi) the outcome of any pending
or potential legal proceedings against Ginkgo, (vii) our ability to
realize the expected benefits from and the success of our Foundry
platform programs, (viii) our ability to successfully develop
engineered cells, bioprocesses, data packages or other
deliverables, and (ix) the product development or commercialization
success of our customers. The foregoing list of factors is not
exhaustive. You should carefully consider the foregoing factors and
the other risks and uncertainties described in the "Risk Factors"
section of Ginkgo's annual report on Form 10-K filed with the U.S.
Securities and Exchange Commission (the "SEC") on February 29, 2024 and other documents filed by
Ginkgo from time to time with the SEC. These filings identify and
address other important risks and uncertainties that could cause
actual events and results to differ materially from those contained
in the forward-looking statements. Forward-looking statements speak
only as of the date they are made. Readers are cautioned not to put
undue reliance on forward-looking statements, and Ginkgo assumes no
obligation and does not intend to update or revise these
forward-looking statements, whether as a result of new information,
future events, or otherwise. Ginkgo does not give any assurance
that it will achieve its expectations.
GINKGO BIOWORKS INVESTOR
CONTACT:
investors@ginkgobioworks.com
GINKGO BIOWORKS MEDIA
CONTACT:
press@ginkgobioworks.com
IL GRANAIO DELLE IDEE CONTACT:
Laura Scarso | Il Granaio delle Idee -
marketing@ilgranaiodelleidee.com
Ginkgo Bioworks is the leading horizontal platform for cell
programming, providing flexible, end-to-end services that solve
challenges for organizations across diverse markets, from food and
agriculture to pharmaceuticals to industrial and specialty
chemicals. Ginkgo Biosecurity is building and deploying the
next-generation infrastructure and technologies that global leaders
need to predict, detect, and respond to a wide variety of
biological threats. For more information, visit ginkgobioworks.com
and ginkgobiosecurity.com, read our blog, or follow us on social
media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram
(@GinkgoBioworks), Threads (@GinkgoBioworks), or LinkedIn.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/il-granaio-delle-idee-and-ginkgo-bioworks-announce-strategic-collaboration-to-optimize-sourdough-strains-for-bakery-products-302117244.html
SOURCE Ginkgo Bioworks
